What does qarziba — financial royalty assets, net mean?

Represents the book value of royalty-based assets after deducting accumulated amortization and allowances for impairment. It provides a clear view of the current net economic value of the product's future cash flow potential on the balance sheet.

Ligand Pharmaceuticals LGND Qarziba — Financial Royalty Assets, Net

Similar metrics at other companies

TPLRoyalty interests acquired, net

$831.45M+94.0%

RGLDRoyalty interest — Stream and royalty interests, net (Note 3)

$4.06B—

BCPCRoyalty Revenue — Net Sales

$493K+7.6%

HALORoyalties — Accounts receivable, net and contract assets

$298.12M+62.4%

BBIODeferred royalty obligations, net

$871.19M+75.2%

RPRXIncome from financial royalty assets — Total income and other revenues

$594.99M+10.3%

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.51B+96.7%

Enterprise value$5.4B+95.4%

P/E35.9×—

P/S20.1×+4.6×

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept lgnd:FinancialRoyaltyAssetsNet.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's qarziba — financial royalty assets, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's qarziba — financial royalty assets, net?: Ligand Pharmaceuticals (LGND) reported qarziba — financial royalty assets, net of $103.24M in Q1 2026.
What does qarziba — financial royalty assets, net mean?: Represents the book value of royalty-based assets after deducting accumulated amortization and allowances for impairment. It provides a clear view of the current net economic value of the product's future cash flow potential on the balance sheet.